Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

Deepak M. W. Balak*, Gerald J. D. Hengstman, Enes Hajdarbegovic, Rob J. P. van den Brule, Raymond M. M. Hupperts, Hok Bing Thio

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Web of Science)
Original languageEnglish
Article number146
JournalBMC Neurology
Issue number1
Publication statusPublished - 16 Oct 2013


  • Skin reactions
  • MS
  • Quality of life
  • Glatiramer acetate
  • Interferon-beta
  • Injections

Cite this